Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: Is Real Circulating Tumor Cell Number Superior to Prostate-Specific Antigen? Reply

G Heller, R McCormack, T Kheoh, A Molina, MR Smith, R Dreicer, F Saad, Ronald de Wit, DT Aftab, M Hirmand, A Limon-Carrera, K Fizazi, M Fleisher, JS de Bono, HI Scher

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2354-2355
Number of pages2
JournalJournal of Clinical Oncology
Issue number22
Publication statusPublished - 2018

Cite this